Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Safety, Tolerance, Efficacy, Pharmacokinetics, and Costs of Therapy With Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia

NCT00152594 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT00152594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00152594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Safety, Tolerance, Efficacy, Pharmacokinetics, and Costs of Therapy With Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
Lead sponsor
University of Cologne
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2004
Completion date
January 31, 2006
Enrollment
150
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myelocytic, acute